Background
PFAPA syndrome, Aphthous Stomatitis, gout, ’s Syndrome
PFAPA SYNDROME, APHTHOUS STOMATITIS, GOUT, DISEASE
Recurrent Aphthous Stomatitis (RAS) is a relatively common oral mucosal condition affecting about 10% of the population with a varied reported prevalence of 1.5-25% [Topical corticosteroids are the mainstay of RAS treatment [Colchicine, is an anti-inflammatory agent with some immunosuppressive action, used for treating gout and other conditions including PFAPA syndrome and Behçet’s Syndrome [Evidence based clinical research requires disease severity assessment and outcome measures. In recent years, oral disease severity scoring systems [